Skip to content
healthcare.dev

ENCELTO

NDC 82958-501, revakinagene taroretcel-lwey, implant, from Neurotech Pharmaceuticals, Inc..

Product NDC
82958-501
Status
Listed
Labeler
Neurotech Pharmaceuticals, Inc.
Dosage form
IMPLANT
Route
INTRAVITREAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
BLA
Application
BLA125798
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/82958-501 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • REVAKINAGENE TARORETCEL-LWEY440000 [arb'U]/1
Package NDCNDC-11Package
82958-501-01829580501011 CAPSULE in 1 CONTAINER (82958-501-01) / 1 IMPLANT in 1 CAPSULE

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/1ae9482a-b478-4e21-9166-b5fd52d3ef9c

Use it

Look up 82958-501 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/82958-501 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 82958-501. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.